In-vitro Toxicology Assays Industry For Cannabis And Nicotine Testing Overview
The in-vitro toxicology assays market size for cannabis and nicotine testing was valued at USD 1,236.1 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.2% from 2021 to 2028.
Rising usage of products based on cannabis and nicotine and the introduction of technologically advanced products are factors driving the in-vitro toxicology assay market for cannabis and nicotine testing. In addition, the rise in an adolescent population, which is more prone to use nicotine and cannabis-related products, will aid in market growth. Furthermore, the number of countries legalizing the use of medical cannabis is expected to increase in the coming years resulting in increasing usage of medical cannabis across the globe. The potential for significant tax revenues from cannabis is another factor that has resulted in an increasing number of counties legalizing its medical use.
Gather more insights about the market drivers, restrains and growth of the Global In-vitro Toxicology Assays For Cannabis And Nicotine Testing Market
In the past few years, awareness regarding medical applications of cannabis (marijuana), such as appetite enhancement, pain management, and reducing eye pressure, is increasing. Owing to this factor, the number of countries legalizing the use of medical cannabis in various parts of this world is continuously increasing. For instance, most U.S. states have legally approved the use and commercialization of medical cannabis and an increasing number of countries are legalizing the plant for recreational use.
The increasing incidence of nicotine consumption-associated diseases has triggered the launch of various policies and initiatives by governments and global organizations to increase awareness among people. For instance, the CDC has initiated a project for reducing the consumption of sodium and tobacco to prevent COPD and cardiac disorders in China.
In recent years, the use of cannabis products has expanded, leading to an increasing number of specialized cannabis testing laboratories. This intensified the market completion. For instance, with rigorous legislative requirements and high sample throughput, Laboratory Information Management Systems (LIMS) serve as a promising tool for a testing laboratory.
Browse through Grand View Research's Biotechnology Industry Research Reports.
- Laboratory Information Management System Market - The global laboratory information management system market size was valued at USD 1.85 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.0% from 2022 to 2030. Technological advancements pertinent to pharmaceutical laboratories and the rising demand for lab automation are expected to fuel the demand for these systems in the years to come.
- Medical Marijuana Market - The global medical marijuana market size was valued at USD 11.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 21.06% from 2022 to 2030. The industry is experiencing growth due to the rising awareness regarding various therapeutic applications of the product, such as pain management, appetite enhancement, and reducing eye pressure.
In-vitro Toxicology Assays For Cannabis And Nicotine Testing Market Segmentation
Grand View Research has segmented the global in-vitro toxicology assays market for cannabis and nicotine testing on the basis of test type, technology, application, method, and region:
In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Type Outlook (Revenue, USD Million, 2017 - 2028)
- Cannabis Testing
- Nicotine Testing
In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Technology Outlook (Revenue, USD Million, 2017 - 2028)
- 3D Cell Culture Technology
- Mass Spectrometry
- Flow Cytometry
- Others
In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Application Outlook (Revenue, USD Million, 2017 - 2028)
- Genetic Toxicity Testing
- Carcinogenicity Testing
- Cytotoxicity Testing
- Mutagenicity Testing
- Others
In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Method Outlook (Revenue, USD Million, 2017 - 2028)
- Cellular Assay
- Live Cells
- High Throughput / High Content Screening
- Molecular Imaging
- Others
- Fixed Cells
- Live Cells
- Others
In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Regional Outlook (Revenue, USD Million, 2017 - 2028)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Market Share Insights
- July 2021: IONTOX announced a collaboration with cbdMD, Inc. to identify novel cannabinoids for therapeutic use. The company is expected to perform the required toxicological studies with cbdMD Therapeutics.
Key Companies profiled:
Some prominent players in the global in-vitro toxicology assays market for cannabis and nicotine testing include
- Stemina Biomarker Discovery, Inc.
- Broughton Nicotine Services
- Labstat International, Inc.
- IONTOX
- TOXIKON
- Integrated Laboratory Systems
- Enthalpy Analytical
- PBR Laboratories, Inc.
Order a free sample PDF of the in-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
